Lisa Percival

Lisa Percival joined Fulcrum in October 2025 as Chief Regulatory & Quality Assurance Officer. Prior to joining Fulcrum, Lisa served as Senior Vice President, Head of Regulatory at Belenos Bio and before that Vividion Therapeutics. Previously, Lisa served as an entrepreneur in residence, regulatory strategy for Atlas Venture stealth companies and as senior vice president, regulatory affairs for Third Harmonic Bio. Prior to joining Atlas, Lisa was Vice President of Regulatory Affairs at Zafgen, where she was responsible for the development and execution of the global regulatory strategy for products to treat metabolic diseases and partnered with the executive team on business strategy. Before Zafgen, Lisa worked for Bristol-Myers Squibb in clinical development and global regulatory strategy and policy, where she led the global pediatric center of excellence in support of all therapeutic areas and led global regulatory teams in virology, immunoscience and fibrosis to successful completion of clinical trials and IND, NDA, MAA and other global submissions and approvals. Lisa holds an M.S. in physiology from the University of Connecticut and a B.S. in biology from Trinity College.